How many insider trades does FilingIQ track for MXCT?

FilingIQ tracks 230 Form 4 insider transactions for MXCT (MAXCYTE, INC.), covering filings from Jul 30, 2021 onwards. 5 of those were filed in the last 90 days.

Are MXCT insiders net buyers or net sellers?

Across the full Form 4 history for MXCT, 10 transactions (4%) were open-market purchases and 96 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MXCT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MXCT in?

MAXCYTE, INC. (MXCT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $80.27M.

MXCT insider trading

NasdaqGS Healthcare

MAXCYTE, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

230

Last 90 days

Buys / sells

4% / 42%

Market cap

$80.27M

About MAXCYTE, INC.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Company website: www.maxcyte.com

MXCT insider activity at a glance

FilingIQ has scored 230 insider transactions for MXCT since Jul 30, 2021. The most recent filing in our index is dated Apr 15, 2026.

Across the full history, 10 open-market purchases and 96 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MXCT insider trades is 63.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MXCT trades on FilingIQ Raw filings on SEC EDGAR

Latest MXCT Form 4 filings

Doerfler Douglas President and CEO

S Dec 5, 2023

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding MXCT

MIRABELLA FINANCIAL SERVICES LLP

$12.96M · 1.1% of AUM

Frequently asked

How many insider trades does FilingIQ track for MXCT?: FilingIQ tracks 230 Form 4 insider transactions for MXCT (MAXCYTE, INC.), covering filings from Jul 30, 2021 onwards. 5 of those were filed in the last 90 days.
Are MXCT insiders net buyers or net sellers?: Across the full Form 4 history for MXCT, 10 transactions (4%) were open-market purchases and 96 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MXCT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MXCT in?: MAXCYTE, INC. (MXCT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $80.27M.

Methodology & sources

Every MXCT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.